| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Accidental sulphamethoxazole poisoning |
Causative agent (attribute) |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Intentional sulfamethoxazole poisoning |
Causative agent (attribute) |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole poisoning of undetermined intent |
Causative agent (attribute) |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Poisoning by sulfamethoxazole |
Causative agent (attribute) |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole + trimethoprim 200mg/40mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole + trimethoprim 400mg/80mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole + trimethoprim 800mg/160mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole 400mg/trimethoprim 80mg infusion solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole 80mg/trimethoprim 16mg infusion solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Product containing sulfamethoxazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole measurement |
Component |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Product containing phenazopyridine hydrochloride and sulfamethoxazole and trimethoprim |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Product containing phenazopyridine and sulfamethoxazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Azo-Sulfamethoxazole |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Accidental sulphamethoxazole poisoning |
Causative agent (attribute) |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Intentional sulfamethoxazole poisoning |
Causative agent (attribute) |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole and trimethoprim poisoning |
Causative agent (attribute) |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Accidental sulfamethoxazole and trimethoprim poisoning |
Causative agent (attribute) |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Intentional sulfamethoxazole and trimethoprim poisoning |
Causative agent (attribute) |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole and trimethoprim poisoning of undetermined intent |
Causative agent (attribute) |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole + trimethoprim adverse reaction |
Causative agent (attribute) |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Allergy to sulfamethoxazole and trimethoprim |
Causative agent (attribute) |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole and trimethoprim overdose |
Causative agent (attribute) |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Accidental sulfamethoxazole and trimethoprim overdose |
Causative agent (attribute) |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Intentional sulfamethoxazole and trimethoprim overdose |
Causative agent (attribute) |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole and trimethoprim overdose of undetermined intent |
Causative agent (attribute) |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Co-trimoxazole 80mg/400mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Co-trimoxazole 160mg/800mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Co-trimoxazole 40mg/80mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Trimethoprim 40mg/Sulfamethoxazole200mg 5mL pediatric suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Co-trimoxazole 16mg/80mg/mL infusion concentrate 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Co-trimoxazole 40mg/200mg/5mL pediatric s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Co-trimoxazole 960mg/10mL intravenous infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Product containing sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole- and trimethoprim-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Adverse reaction to sulfamethoxazole |
Causative agent (attribute) |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Co-trimoxazole [generic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Co-trimoxazole [proprietary] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Co-trimoxazole 16mg/80mg/mL infusion solution 20mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Allergy to sulfamethoxazole and trimethoprim |
Causative agent (attribute) |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
4 |
| Sulfamethoxazole and trimethoprim |
Is a |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
3 |
| Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Sulfamethoxazole 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
3 |
| Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Sulfamethoxazole and trimethoprim |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
|
| Product containing precisely sulfamethoxazole 800 milligram/10 milliliter and trimethoprim 160 milligram/10 milliliter conventional release solution for infusion ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely sulfamethoxazole 800 milligram/10 milliliter and trimethoprim 160 milligram/10 milliliter conventional release solution for infusion ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Sulfamethoxazole 40 mg/mL and trimethoprim 8 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 40 mg/mL and trimethoprim 8 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing phenazopyridine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Product containing sulfamethoxazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Phenazopyridine- and sulfamethoxazole- and trimethoprim-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Phenazopyridine and sulfamethoxazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Phenazopyridine and sulfamethoxazole and trimethoprim only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Sulfamethoxazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only phenazopyridine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Sulfamethoxazole and trimethoprim only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole and trimethoprim only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only sulfamethoxazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Allergy to sulfamethoxazole and trimethoprim |
Causative agent (attribute) |
False |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing isoniazid and pyridoxine and sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Isoniazid- and pyridoxine- and sulfamethoxazole- and trimethoprim-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Isoniazid and pyridoxine and sulfamethoxazole and trimethoprim only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely isoniazid 300 milligram and pyridoxine hydrochloride 25 milligram and sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely isoniazid 300 milligram and pyridoxine hydrochloride 25 milligram and sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sulfamethoxazole (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]